Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News InMed Pharmaceuticals Inc INM

Healthcare Cannabis
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INM)

InMed to Present at the Emerging Growth Conference

Newsfile 8 days ago

InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

Newsfile May 14, 2024

InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

Newsfile April 18, 2024

InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration

Newsfile April 16, 2024

InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies

Newsfile April 4, 2024

InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance

Newsfile March 20, 2024

InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update

Newsfile February 13, 2024

InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer

Newsfile February 9, 2024

InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET

Newsfile January 18, 2024
View More News ››

Opinion & Analysis (NDAQ:INM)

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

Streetwise Reports January 21, 2020

The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

Hannah Genig April 1, 2019

Cannabis Technologies (C.CAN) lays out clear path to creating shareholder value

Stockhouse Editorial June 23, 2014
View More Opinion ››

Bullboard Posts (NDAQ:INM)

InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM

Just In: $INM InvestorNewsBreaks - InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth...
whytestocks - 7 days ago

InMed to Present at the Emerging Growth Conference

JUST IN: $INM InMed to Present at the Emerging Growth ConferenceVancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - InMed...
whytestocks - 8 days ago

Positive In Vivo Preclinical Alzheimer’s results

https://mailchi.mp/02da2462c4f8/inmeds-inm-901-demonstrates-favorable-pharmacological-and-behavioral-effects-in-in-vivo-preclinical...
zardoz00 - April 4, 2024

Good update on Inmed

https://wallstreetwaves.com/inmed-pharmaceuticals-has-multiple-milestones-coming-up-in-2024-with-a-focus-on-three-conditions-with-an...
zardoz00 - January 25, 2024

INM revenues have been exploding

https://mailchi.mp/550c403a5512/inmed-provides-update-on-baymedica-rare-cannabinoid-business?e=5815d309bc
zardoz00 - July 27, 2023

Minor Cannabinoid Sales - Ray of Hope

https://youtu.be/lTC25Wcj04I
Bullknit101 - June 11, 2023
View more Bullboard ››

Grid Battery Metals Inc.

Grid Battery Metals Inc.

Grid Battery Metals Inc. is a Canada-based exploration company. The Company focuses on exploration for high-value battery ...
View More »